C

Cyclerion Therapeutics
D

CYCN

1.46000
USD
0.03
(2.10%)
Market Closed
Volume
2,624
EPS
-1
Div Yield
-
P/E
-1
Market Cap
3,956,740
OverviewSignalsIdeasNews
Related Instruments
    A
    ADVM
    -0.40000
    (-5.51%)
    6.86000 USD
    A
    AQST
    -0.13000
    (-2.84%)
    4.44500 USD
    G
    GRTS
    0
    (0%)
    0.000000 USD
    J
    JAGX
    -0.08040
    (-7.73%)
    0.95960 USD
    R
    RCKT
    -0.810
    (-5.48%)
    13.980 USD
    S
    SELB
    -0.07020
    (-7.39%)
    0.88010 USD
    More
News

Title: Cyclerion Therapeutics

Sector: Healthcare
Industry: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.